To be blunt, research is expensive. C3 has awarded over $2.5 million in grants to support high quality research focused solely on Calpainopathy. Help us continue our commitment to invest in the scientific community dedicated to our cause to drive research towards a cure. As a community working together, we are "overcoming weakness with strength."
|